{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T21:31:33Z","timestamp":1792359093863,"version":"4.4.0"},"update-to":[{"DOI":"10.1002\/14651858.cd015134","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T00:00:00Z","timestamp":1714608000000}}],"reference-count":72,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd015134.pub2","type":"journal-article","created":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T14:19:18Z","timestamp":1714659558000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Respiratory syncytial virus vaccination during pregnancy for improving infant outcomes"],"prefix":"10.1002","volume":"2024","author":[{"given":"Emily WEM","family":"Phijffer","sequence":"additional","affiliation":[{"name":"Department of Paediatric Infectious Diseases and Immunology; Wilhelmina Children's Hospital, University Medical Center Utrecht; Utrecht Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odette","family":"de Bruin","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Division Woman and Baby; Wilhelmina Children's Hospital, University Medical Center Utrecht; Utrecht Netherlands"},{"name":"Department of Data Science & Biostatistics, Julius Global Health; University Medical Center Utrecht; Utrecht Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariba","family":"Ahmadizar","sequence":"additional","affiliation":[{"name":"Department of Data Science & Biostatistics, Julius Global Health; University Medical Center Utrecht; Utrecht Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis J","family":"Bont","sequence":"additional","affiliation":[{"name":"Department of Paediatric Infectious Diseases and Immunology; Wilhelmina Childrens Hospital, University Medical Center Utrecht; Utrecht Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoline AT","family":"Van der Maas","sequence":"additional","affiliation":[{"name":"Centre for Infectious Disease Control; National Institute for Public Health and the Environment; Bilthoven Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam CJM","family":"Sturkenboom","sequence":"additional","affiliation":[{"name":"Department of Data Science & Biostatistics, Julius Global Health; University Medical Center Utrecht; Utrecht Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne G","family":"Wildenbeest","sequence":"additional","affiliation":[{"name":"Department of Paediatric Infectious Diseases and Immunology; Wilhelmina Childrens Hospital, University Medical Center Utrecht; Utrecht Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kitty WM","family":"Bloemenkamp","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Division Woman and Baby; Wilhelmina Childrens Hospital, University Medical Center Utrecht; Utrecht Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,5,2]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD015134.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/infdis\/jiad024","article-title":"Safety and immunogenicity of an investigational respiratory syncytial virus vaccine (RSVPreF3) in mothers and their infants: a phase 2 randomized trial","volume":"228","author":"Bebia","year":"2023","journal-title":"Journal of infectious diseases"},{"key":"10.1002\/14651858.CD015134.pub2-BIB0002|cit2","unstructured":"Study of safety, reactogenicity and immunogenicity of GlaxoSmithKlinea\u00e2\u201a\u00ac\u00e2\u201e\u00a2s (GSK)Respiratory Syncytial Virus (RSV)maternal unadjuvanted vaccine in healthy pregnant women (aged 18 to 40 years) and their infants trialsearch.who.int\/Trial2.aspx?TrialID=EUCTR2019-001991-12-ES"},{"key":"10.1002\/14651858.CD015134.pub2-BIB0003|cit3","unstructured":"Study of safety, reactogenicity and immunogenicity of glaxosmithkline's (GSK)respiratory syncytial virus (RSV)maternal unadjuvanted vaccine in healthy pregnant women (aged 18 to 40 years) and their infants clinicaltrials.gov\/show\/nct04126213"},{"key":"10.1002\/14651858.CD015134.pub2-BIB0004|cit4","unstructured":"Dieussaert I Dormitzer PR Kim JH Luik S Seidl C Stegmann JU 126. Preterm birth signal in a maternal immunization study with a respiratory syncytial virus prefusion f protein vaccine candidate Abstract Booklet RSVVW'23 2023"},{"key":"10.1002\/14651858.CD015134.pub2-BIB0005|cit5","unstructured":"A phase III double-blind study to assess safety and efficacy of an RSV Maternal unadjuvanted vaccine, in pregnant women and infants born to vaccinated mothers trialsearch.who.int\/Trial2.aspx?TrialID=EUCTR2020-001355-40-FI"},{"key":"10.1002\/14651858.CD015134.pub2-BIB0006|cit6","unstructured":"A phase iii double-blind study to assess safety and efficacy of an rsv maternal unadjuvanted vaccine, in pregnant women and infants born to vaccinated mothers clinicaltrials.gov\/show\/NCT04605159"},{"key":"10.1002\/14651858.CD015134.pub2-BIB0007|cit7","unstructured":"RSVPreF3 OA. Sponsor briefing document. Vaccines and related biological products advisory committee Meeting Briefing Document - Sponsor GSK (fda.gov\/media\/165621\/download) 2023"},{"key":"10.1002\/14651858.CD015134.pub2-BIB0008|cit8","unstructured":"A trial to evaluate the efficacy and safety of a respiratory syncytial virus (RSV) prefusion F subunit vaccine in infants born to women vaccinated during pregnancy trialsearch.who.int\/Trial2.aspx?TrialID=EUCTR2019-002943-85-DK"},{"issue":"16","key":"10.1002\/14651858.CD015134.pub2-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2216480","article-title":"Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants","volume":"388","author":"Kampmann","year":"2023","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD015134.pub2-BIB0010|cit10","unstructured":"A trial to evaluate the efficacy and safety of RSVpreF in infants born to women vaccinated during pregnancy clinicaltrials.gov\/show\/NCT04424316"},{"key":"10.1002\/14651858.CD015134.pub2-BIB0011|cit11","unstructured":"A phase 3, randomized, double-blinded, placebo-controlled trial to evaluate the efficacy and safety of a respiratory syncytial virus (RSV) prefusion F subunit vaccine in infants born to women vaccinated during pregnancy trialsearch.who.int\/Trial2.aspx?TrialID=PACTR202101800162440"},{"key":"10.1002\/14651858.CD015134.pub2-BIB0012|cit12","unstructured":"Saleem S Pfizer announces positive top-line data of phase 3 global maternal immunization trial for its bivalent respiratory syncytial virus (RSV) vaccine candidate Neonatology Today 2022 17 11 131 4"},{"key":"10.1002\/14651858.CD015134.pub2-BIB0013|cit13","unstructured":"A study to determine the safety and effectiveness of the RSV f vaccine to protect infants via maternal vaccination trialsearch.who.int\/Trial2.aspx?TrialID=CTRI\/2017\/09\/009821"},{"key":"10.1002\/14651858.CD015134.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"S765","DOI":"10.1093\/ofid\/ofy229.2193","article-title":"Progress toward a vaccine for maternal immunization to prevent respiratory syncytial virus (RSV) lower respiratory tract illness (LRTI) in infants","volume":"5","author":"Fries","year":"2018","journal-title":"Open Forum Infectious Diseases"},{"key":"10.1002\/14651858.CD015134.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"S921","DOI":"10.1093\/ofid\/ofz360.2315","article-title":"Third trimester immunization with an respiratory syncytial virus F protein vaccine for the prevention of RSV lower respiratory tract infection in infants","volume":"6","author":"Fries","year":"2019","journal-title":"Open Forum Infectious Diseases"},{"issue":"12","key":"10.1002\/14651858.CD015134.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"e2112410119","DOI":"10.1073\/pnas.2112410119","article-title":"Prevention of antimicrobial prescribing among infants following maternal vaccination against respiratory syncytial virus","volume":"119","author":"Lewnard","year":"2022","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5","key":"10.1002\/14651858.CD015134.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1056\/NEJMoa1908380","article-title":"Respiratory syncytial virus vaccination during pregnancy and effects in infants","volume":"383","author":"Madhi","year":"2020","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD015134.pub2-BIB0018|cit18","unstructured":"A study to determine the safety and efficacy of the RSV F vaccine to protect infants via maternal immunization clinicaltrials.gov\/show\/nct02624947"},{"issue":"6","key":"10.1002\/14651858.CD015134.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ajog.2019.10.080","article-title":"Immunoglobulin A, immunoglobulin G, and neutralizing antibodies to respiratory syncytial virus increase in human milk following immunization with an RSV f protein vaccine","volume":"221","author":"Shakib","year":"2019","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD015134.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.ajog.2019.10.081","article-title":"Safety of third trimester immunization with a respiratory syncytial virus F protein vaccine and protection of infants over the first 180 days of life against all-cause lower respiratory tract infection","volume":"221","author":"Swamy","year":"2019","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"11","key":"10.1002\/14651858.CD015134.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1093\/infdis\/jiz390","article-title":"Safety and immunogenicity of a respiratory syncytial virus fusion (F) protein nanoparticle vaccine in healthy third-trimester pregnant women and their infants","volume":"220","author":"Mu\u0148oz","year":"2019","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD015134.pub2-BIB0022|cit22","unstructured":"RSV F vaccine maternal immunization study in healthy third-trimester pregnant women clinicaltrials.gov\/show\/nct02247726"},{"key":"10.1002\/14651858.CD015134.pub2-BIB0023|cit23","unstructured":"A phase 2b placebo-controlled, randomized study of a respiratory syncytial virus (RSV) vaccine in pregnant women clinicaltrials.gov\/show\/nct04032093"},{"issue":"17","key":"10.1002\/14651858.CD015134.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1056\/NEJMoa2106062","article-title":"Prefusion F protein-based respiratory syncytial virus immunization in pregnancy","volume":"386","author":"Simoes","year":"2022","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD015134.pub2-BIB0025|cit25","doi-asserted-by":"crossref","unstructured":"Simoes EA Madhi SA Center KJ 91. Establishing proof of concept for a bivalent RSVpreF subunit vaccine for maternal immunization Open Forum Infectious Diseases 2022 9 10.1093\/ofid\/ofac492.016","DOI":"10.1093\/ofid\/ofac492.016"},{"key":"10.1002\/14651858.CD015134.pub2-BIB0026|cit26","unstructured":"Mu\u0148oz FM Piedra PA Schoonover SL Jewel AM Glezen P Maternal immunization with respiratory syncytial virus (RSV) vaccine - effect on breast milk antibodies [abstract] Pediatric Academic Societies Annual Meeting; 2003 May 3-6; Seattle, Washington, USA 2003"},{"key":"10.1002\/14651858.CD015134.pub2-BIB0027|cit27","unstructured":"A study to evaluate the safety, reactogenicity and immunogenicity of the GSK investigational vaccine GSK3003891A in healthy pregnant women and infants born to vaccinated mothers trialsearch.who.int\/Trial2.aspx?TrialID=EUCTR2016-002733-30-ES"},{"key":"10.1002\/14651858.CD015134.pub2-BIB0028|cit28","unstructured":"A study to evaluate the safety, reactogenicity and immunogenicity of the glaxosmithkline (GSK) biologicals' respiratory syncytial virus (RSV) investigational vaccine (GSK3003891A) in healthy pregnant women and infants born to vaccinated mothers clinicaltrials.gov\/show\/nct03191383"},{"issue":"5","key":"10.1002\/14651858.CD015134.pub2-BIB0029|cit29","first-page":"389","article-title":"Respiratory syncytial virus vaccination in pregnancy is not effective enough at reducing infant infections","volume":"107","author":"Wesley","year":"2022","journal-title":"Archives of Disease in Childhood: Education and Practice Edition"},{"issue":"24","key":"10.1002\/14651858.CD015134.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1016\/S0264-410X(03)00352-9","article-title":"Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women","volume":"21","author":"Mu\u0148oz","year":"2003","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD015134.pub2-BIB0031|cit31","unstructured":"A study on the safety and immune response to an unadjuvanted RSV Maternal vaccine, in high risk pregnant women aged 15 to 49 years and infants born to the vaccinated mothers trialsearch.who.int\/Trial2.aspx?TrialID=CTRI\/2021\/10\/037383"},{"key":"10.1002\/14651858.CD015134.pub2-BIB0032|cit32","unstructured":"A study on the safety and immune response to an unadjuvanted RSV Maternal vaccine, in high risk pregnant women aged 15 to 49 years and infants born to the vaccinated mothers trialsearch.who.int\/Trial2.aspx?TrialID=EUCTR2021-000994-96-ES"},{"key":"10.1002\/14651858.CD015134.pub2-BIB0033|cit33","unstructured":"A study on the safety and immune response to an unadjuvanted RSV maternal vaccine, in high risk pregnant women aged 15 to 49 years and infants born to the vaccinated mothers clinicaltrials.gov\/show\/NCT04980391"},{"issue":"7","key":"10.1002\/14651858.CD015134.pub2-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"e209","DOI":"10.1016\/S1473-3099(17)30190-1","article-title":"Pertussis and influenza immunisation during pregnancy: a landscape review","volume":"17","author":"Abu Raya","year":"2017","journal-title":"Lancet Infectious Diseases"},{"key":"10.1002\/14651858.CD015134.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/anae.13938","article-title":"Data fabrication and other reasons for non-random sampling in 5087 randomised, controlled trial in anaesthetic and general medical journals","volume":"72","author":"Carlisle","year":"2017","journal-title":"Anaesthesia"},{"key":"10.1002\/14651858.CD015134.pub2-BIB0036|cit36","unstructured":"Centers for Disease Control and Prevention Pregnancy and Vaccination Vaccines during and after pregnancy www.cdc.gov\/vaccines\/pregnancy\/vacc-during-after.html"},{"key":"10.1002\/14651858.CD015134.pub2-BIB0037|cit37","unstructured":"Centers for Disease Control and Prevention Transmission of RSV (Respiratory Syncytial Virus) www.cdc.gov\/rsv\/about\/transmission.html"},{"issue":"4","key":"10.1002\/14651858.CD015134.pub2-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/cid\/ciu327","article-title":"Maternal immunization","volume":"59","author":"Chu","year":"2014","journal-title":"Clinical Infectious Diseases"},{"issue":"10","key":"10.1002\/14651858.CD015134.pub2-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1093\/infdis\/jiu316","article-title":"Respiratory syncytial virus transplacental antibody transfer and kinetics in mother-infant pairs in Bangladesh","volume":"210","author":"Chu","year":"2014","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD015134.pub2-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/bdra.23547","article-title":"Maternal immunization","volume":"109","author":"Chu","year":"2017","journal-title":"Birth Defects Research"},{"key":"10.1002\/14651858.CD015134.pub2-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jcv.2017.08.017.","article-title":"Transplacental transfer of maternal respiratory syncytial virus (RSV) antibody and protection against RSV disease in infants in rural Nepal","volume":"95","author":"Chu","year":"2017","journal-title":"Journal of Clinical Virology"},{"issue":"1","key":"10.1002\/14651858.CD015134.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/humupd\/dmu041","article-title":"Maternal vaccination: moving the science forward","volume":"21","author":"Faucette","year":"2015","journal-title":"Human Reproduction Update"},{"key":"10.1002\/14651858.CD015134.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0022-3476(81)80829-3","article-title":"Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level","volume":"98","author":"Glezen","year":"1981","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD015134.pub2-BIB0044|cit44","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) 2022"},{"key":"10.1002\/14651858.CD015134.pub2-BIB0045|cit45","unstructured":"Vaccines and Related Biological Products Advisory Committee Meeting briefing document - sponsor GSK (fda.gov) www.fda.gov\/media\/165621\/download 2023"},{"key":"10.1002\/14651858.CD015134.pub2-BIB0046|cit46","first-page":"1","article-title":"Maternal RSV vaccine development. Where to from here?","volume":"11","author":"Gunatilaka","year":"2021","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"2","key":"10.1002\/14651858.CD015134.pub2-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"e341","DOI":"10.1542\/peds.2013-0303","article-title":"Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age","volume":"132","author":"Hall","year":"2013","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD015134.pub2-BIB0048|cit48","unstructured":"Higgins JP Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"key":"10.1002\/14651858.CD015134.pub2-BIB0049|cit49","unstructured":"Higgins JP Eldridge S Li T Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022) Available from training.cochrane.org\/handbook\/archive\/v6.3 2022"},{"issue":"10340","key":"10.1002\/14651858.CD015134.pub2-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis","volume":"399","author":"Li","year":"2022","journal-title":"Lancet"},{"issue":"8","key":"10.1002\/14651858.CD015134.pub2-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1097\/INF.0000000000002666","article-title":"Respiratory syncytial virus-related death in children with down syndrome: the RSV GOLD Study","volume":"39","author":"L\u00f6wensteyn","year":"2020","journal-title":"Pediatric Infectious Disease Journal"},{"key":"10.1002\/14651858.CD015134.pub2-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1056\/NEJMOA1908380","article-title":"Respiratory syncytial virus vaccination during pregnancy and effects in infants","volume":"383","author":"Madhi","year":"2020","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD015134.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1600-0897.1996.tb00172.x","article-title":"Evolution of maternofetal transport of immunoglobulins during human pregnancy","volume":"36","author":"Malek","year":"1996","journal-title":"American Journal of Reproductive Immunology"},{"issue":"10","key":"10.1002\/14651858.CD015134.pub2-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S1473-3099(18)30292-5","article-title":"The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates","volume":"18","author":"Mazur","year":"2018","journal-title":"Lancet"},{"issue":"22","key":"10.1002\/14651858.CD015134.pub2-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"00291","DOI":"10.1016\/S1473-3099(22)00291-2","article-title":"Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape","volume":"S1473-3099","author":"Mazur","year":"2022","journal-title":"Lancet Infectious Diseases"},{"issue":"11","key":"10.1002\/14651858.CD015134.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1093\/infdis\/jiz390","article-title":"Safety and immunogenicity of a respiratory syncytial virus fusion (F) protein nanoparticle vaccine in healthy third-trimester pregnant women and their infants","volume":"220","author":"Mu\u0148oz","year":"2019","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD015134.pub2-BIB0057|cit57","unstructured":"A phase III double-blind study to assess safety and efficacy of an RSV maternal unadjuvanted vaccine, in pregnant women and infants born to vaccinated mothers (GRACE) clinicaltrials.gov\/ct2\/show\/NCT04605159"},{"issue":"5","key":"10.1002\/14651858.CD015134.pub2-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"e0177803","DOI":"10.1371\/journal.pone.0177803","article-title":"Defining the vaccination window for respiratory syncytial virus (RSV) using age-seroprevalence data for children in Kilifi, Kenya","volume":"12","author":"Nyiro","year":"2017","journal-title":"PLOS ONE"},{"issue":"12","key":"10.1002\/14651858.CD015134.pub2-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"e08088","DOI":"10.1371\/journal.pone.0008088","article-title":"The level and duration of RSV-specific maternal IgG in infants in Kilifi Kenya","volume":"4","author":"Ochola","year":"2009","journal-title":"PLOS ONE"},{"key":"10.1002\/14651858.CD015134.pub2-BIB0060|cit60","unstructured":"PATH RSV vaccine and mAb snapshot - PATH vaccine resource library www.path.org\/resources\/rsv-and-mab-trial-tracker"},{"key":"10.1002\/14651858.CD015134.pub2-BIB0061|cit61","unstructured":"Respiratory Syncytial Virus Bivalent Stabilized Prefusion F Subunit Vaccine (RSVpreF) VRBPAC Briefing Document www.fda.gov\/media\/168186\/download"},{"issue":"10","key":"10.1002\/14651858.CD015134.pub2-BIB0062|cit62","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015134","article-title":"Respiratory syncytial virus vaccination during pregnancy for improving infant outcomes","author":"Phijffer","year":"2022","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD015134.pub2-BIB0063|cit63","first-page":"282","article-title":"Transaplacentally transmitted anti-measles antibodies in term and preterm infants","volume":"39","author":"Rau","year":"2002","journal-title":"Indian Pediatrics"},{"key":"10.1002\/14651858.CD015134.pub2-BIB0064|cit64","unstructured":"Review Manager 5 (RevMan 5) The Cochrane Collaboration 2020"},{"issue":"31","key":"10.1002\/14651858.CD015134.pub2-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.1016\/j.vaccine.2018.06.021","article-title":"Potential impact of maternal vaccination on life-threatening respiratory syncytial virus infection during infancy","volume":"36","author":"Scheltema","year":"2018","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD015134.pub2-BIB0066|cit66","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013 Available from gdt.guidelinedevelopment.org\/app\/handbook\/handbook.html"},{"issue":"4","key":"10.1002\/14651858.CD015134.pub2-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1002\/ppul.23570","article-title":"Respiratory syncytial virus hospitalization and mortality: systematic review and meta-analysis","volume":"52","author":"Stein","year":"2017","journal-title":"Pediatric Pulmonology"},{"issue":"2","key":"10.1002\/14651858.CD015134.pub2-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.earlhumdev.2010.11.003","article-title":"Transplacental transport of IgG antibodies to preterm infants: a review of the literature","volume":"87","author":"den Berg","year":"2011","journal-title":"Early Human Development"},{"issue":"4","key":"10.1002\/14651858.CD015134.pub2-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"e94714","DOI":"10.1371\/journal.pone.0094714","article-title":"Lower transplacental antibody transport for measles, mumps, rubella and varicella zoster in very preterm infants","volume":"9","author":"den Berg","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1002\/14651858.CD015134.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/infdis\/jiy106","article-title":"Virus-specific antibody, viral load, and disease severity in respiratory syncytial virus infection","volume":"218","author":"Walsh","year":"2018","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD015134.pub2-BIB0071|cit71","unstructured":"World Health Organization WHO preferred product characteristics for Respiratory Syncytial Virus (RSV) vaccines. World Health Organization. License: CC BY-NC-SA 3.0 IGO apps.who.int\/iris\/handle\/10665\/258705"},{"key":"10.1002\/14651858.CD015134.pub2-BIB0072|cit72","unstructured":"World Health Organization Fact sheet preterm birth www.who.int\/news-room\/fact-sheets\/detail\/preterm-birth"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T13:47:41Z","timestamp":1750081661000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD015134.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Pregnancy and Childbirth Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,5,2]]},"references-count":72,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd015134.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,2]]}}}